| 1 |
34262860 | Tumor Microenvironment Alters Chemoresistance of Hepatocellular Carcinoma Through CYP3A4 Metabolic Activity. | 2021 |
1 |
| 2 |
34359887 | In Vitro Cell Toxicity and Intracellular Uptake of Doxorubicin Exposed as a Solution or Liposomes: Implications for Treatment of Hepatocellular Carcinoma. | 2021 Jul 6 |
2 |
| 3 |
31136710 | Development of Liposomal Gemcitabine with High Drug Loading Capacity. | 2019 Jul 1 |
1 |
| 4 |
31330834 | Liver Cancer Cell Lines Treated with Doxorubicin under Normoxia and Hypoxia: Cell Viability and Oncologic Protein Profile. | 2019 Jul 20 |
1 |
| 5 |
31517418 | Isolation of senescent cells by iodixanol (OptiPrep) density gradient-based separation. | 2019 Nov |
2 |
| 6 |
28560008 | GC7 blocks epithelial-mesenchymal transition and reverses hypoxia-induced chemotherapy resistance in hepatocellular carcinoma cells. | 2017 |
1 |
| 7 |
28874716 | Cell Spheroids with Enhanced Aggressiveness to Mimic Human Liver Cancer In Vitro and In Vivo. | 2017 Sep 5 |
1 |
| 8 |
29107422 | Synthesis, antitumor evaluation and microarray study of some new pyrazolo[3,4-d][1,2,3]triazine derivatives. | 2017 Dec 1 |
1 |
| 9 |
27138141 | MiR-122 Reverses the Doxorubicin-Resistance in Hepatocellular Carcinoma Cells through Regulating the Tumor Metabolism. | 2016 |
4 |
| 10 |
27391339 | Downregulating serine hydroxymethyltransferase 2 (SHMT2) suppresses tumorigenesis in human hepatocellular carcinoma. | 2016 Aug 16 |
1 |
| 11 |
27399668 | Gingerol Synergizes the Cytotoxic Effects of Doxorubicin against Liver Cancer Cells and Protects from Its Vascular Toxicity. | 2016 Jul 8 |
1 |
| 12 |
27697528 | Doxorubicin-induced epithelial-mesenchymal transition through SEMA 4A in hepatocellular carcinoma. | 2016 Oct 28 |
1 |
| 13 |
28051262 | Bioinformatic identification of IGF1 as a hub gene in hepatocellular carcinoma (HCC) and in-vitro analysis of the chemosensitizing effect of miR-379 via suppressing the IGF1/IGF1R signaling pathway. | 2016 Dec |
3 |
| 14 |
26744621 | Synergistic interaction between lipid-loading and doxorubicin exposure in Huh7 hepatoma cells results in enhanced cytotoxicity and cellular oxidative stress: implications for acute and chronic care of obese cancer patients. | 2015 Nov 19 |
3 |
| 15 |
24686546 | FBW7 increases chemosensitivity in hepatocellular carcinoma cells through suppression of epithelial-mesenchymal transition. | 2014 Apr |
1 |
| 16 |
25158113 | Identification of sialylated glycoproteins in Doxorubicin-treated hepatoma cells with glycoproteomic analyses. | 2014 Nov 7 |
2 |
| 17 |
24021537 | Didox potentiates the cytotoxic profile of doxorubicin and protects from its cardiotoxicity. | 2013 Oct 15 |
2 |
| 18 |
22581584 | ADAM10 overexpression confers resistance to doxorubicin-induced apoptosis in hepatocellular carcinoma. | 2012 Oct |
1 |
| 19 |
22781398 | NSC 74859 enhances doxorubicin cytotoxicity via inhibition of epithelial-mesenchymal transition in hepatocellular carcinoma cells. | 2012 Dec 28 |
1 |
| 20 |
23097677 | Elimination of cancer stem-like "side population" cells in hepatoma cell lines by chinese herbal mixture "tien-hsien liquid". | 2012 |
1 |
| 21 |
21480327 | Activation of v-Myb avian myeloblastosis viral oncogene homolog-like2 (MYBL2)-LIN9 complex contributes to human hepatocarcinogenesis and identifies a subset of hepatocellular carcinoma with mutant p53. | 2011 Apr |
1 |
| 22 |
19376607 | Additive effect of apicidin and doxorubicin in sulfatase 1 expressing hepatocellular carcinoma in vitro and in vivo. | 2009 Jun |
1 |
| 23 |
17901981 | siRNA mediated the type 1 insulin-like growth factor receptor and epidermal growth factor receptor silencing induces chemosensitization of liver cancer cells. | 2008 Apr |
1 |
| 24 |
16239320 | Characterization of a side population of cancer cells from human gastrointestinal system. | 2006 Mar |
1 |
| 25 |
16036217 | Cdc2 and Cdk2 play critical roles in low dose doxorubicin-induced cell death through mitotic catastrophe but not in high dose doxorubicin-induced apoptosis. | 2005 Sep 9 |
1 |
| 26 |
16226226 | EGFR blockade by cetuximab alone or as combination therapy for growth control of hepatocellular cancer. | 2005 Nov 25 |
1 |
| 27 |
11855756 | Doxorubicin-induced apoptosis and chemosensitivity in hepatoma cell lines. | 2002 Jan |
3 |